Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation.
Saved in:
| Title: | Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. |
|---|---|
| Authors: | Playa-Albinyana H; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain., Arenas F; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain., Royo R; Barcelona Supercomputing Center (BSC), Barcelona, Spain., Giró A; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., López-Oreja I; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain., Aymerich M; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain., López-Guerra M; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain., Frigola G; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Beà S; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Delgado J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematology Department, Hospital Clínic, Barcelona, Spain.; Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Garcia-Roves PM; University of Barcelona, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain., Campo E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Nadeu F; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Colomer D; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. dcolomer@clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain. dcolomer@clinic.cat.; University of Barcelona, Barcelona, Spain. dcolomer@clinic.cat.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain. dcolomer@clinic.cat. |
| Source: | Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 557-569. Date of Electronic Publication: 2023 Nov 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38017105 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Playa-Albinyana+H%22">Playa-Albinyana H</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Arenas+F%22">Arenas F</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Royo+R%22">Royo R</searchLink>; Barcelona Supercomputing Center (BSC), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Giró+A%22">Giró A</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22López-Oreja+I%22">López-Oreja I</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Aymerich+M%22">Aymerich M</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22López-Guerra+M%22">López-Guerra M</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Frigola+G%22">Frigola G</searchLink>; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Beà+S%22">Beà S</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Delgado+J%22">Delgado J</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematology Department, Hospital Clínic, Barcelona, Spain.; Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Roves+PM%22">Garcia-Roves PM</searchLink>; University of Barcelona, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Campo+E%22">Campo E</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Nadeu+F%22">Nadeu F</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain.; Molecular Pathology of Lymphoid Neoplasms Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Colomer+D%22">Colomer D</searchLink>; Experimental Therapeutics in Lymphoid Malignancies Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. dcolomer@clinic.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Barcelona, Spain. dcolomer@clinic.cat.; University of Barcelona, Barcelona, Spain. dcolomer@clinic.cat.; Hematopathology Section, Pathology Department, Hospital Clínic, Barcelona, Spain. dcolomer@clinic.cat. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2024 Mar; Vol. 38 (3), pp. 557-569. <i>Date of Electronic Publication: </i>2023 Nov 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38017105 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-023-02095-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 557 Titles: – TitleFull: Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Playa-Albinyana H – PersonEntity: Name: NameFull: Arenas F – PersonEntity: Name: NameFull: Royo R – PersonEntity: Name: NameFull: Giró A – PersonEntity: Name: NameFull: López-Oreja I – PersonEntity: Name: NameFull: Aymerich M – PersonEntity: Name: NameFull: López-Guerra M – PersonEntity: Name: NameFull: Frigola G – PersonEntity: Name: NameFull: Beà S – PersonEntity: Name: NameFull: Delgado J – PersonEntity: Name: NameFull: Garcia-Roves PM – PersonEntity: Name: NameFull: Campo E – PersonEntity: Name: NameFull: Nadeu F – PersonEntity: Name: NameFull: Colomer D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2024 Mar Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 38 – Type: issue Value: 3 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |